Understanding the Clinical Scenario
This question presents a 4-year-old child with HIV infection who has developed oral candidiasis (thrush). The key clinical findings are white patches on the tongue and inner cheeks that cannot be wiped off, mouth pain, and difficulty swallowing. The child's CD4+ count is
150 cells/mm³, which indicates severe immunosuppression. For a child this age, a CD4+ count below
200 cells/mm³ is a criterion for severe immunologic suppression and an AIDS-defining condition.
Why the Correct Answer is Administering Prescribed Antifungal Medication
The priority intervention is to administer the prescribed antifungal medication and monitor for therapeutic response. This is the correct answer because it directly addresses the underlying pathophysiology of the condition. Oral candidiasis in an HIV-positive child with a CD4+ count of
150 cells/mm³ is not a simple superficial infection; it represents a significant opportunistic infection resulting from profound immunodeficiency. The research on oropharyngeal manifestations in HIV patients highlights that such ENT signs are critical markers of disease progression and treatment failure, particularly in advanced stages of HIV infection
[1]. Therefore, systemic antifungal therapy is the cornerstone of treatment to clear the infection, prevent its spread to the esophagus (which is likely given the dysphagia), and reduce the risk of systemic dissemination.
The case study of a child with profound CD4+ lymphopenia and severe oral candidiasis reinforces this principle. In that report, treatment with intravenous fluconazole resulted in rapid clinical improvement, underscoring the necessity of prompt, targeted antifungal therapy in immunocompromised pediatric patients
[2]. While the child in that specific case was HIV-negative, the clinical parallel is strong: severe oral candidiasis in the setting of a critically low CD4+ count demands immediate systemic treatment to compensate for the body's inability to fight the infection. Topical comfort measures are supportive but do not treat the infection itself.
Analysis of Incorrect Options
-
Option 1 (Hydrogen peroxide rinse): This is not appropriate for a young child and can be an irritant, causing further mucosal breakdown and pain. More importantly, it is a local cleansing measure that does not address the systemic fungal infection in an immunocompromised host.
-
Option 2 (Topical anesthetic gel before meals): While managing pain to facilitate oral intake is a valid comfort measure, it is not the priority. Pain is a symptom of the uncontrolled infection. Treating the infection with antifungals will resolve the pain at its source. Applying anesthetic gel before the antifungal treatment could also interfere with medication administration and absorption.
-
Option 4 (Fluid and soft diet): This is a supportive nutritional intervention to maintain hydration and caloric intake while the child has mouth pain and dysphagia. However, it does not treat the candidiasis. The infection will persist and potentially worsen without antifungal therapy, making nutritional support ineffective in the long run.
Clinical Reasoning and Test-Taking Strategy
When prioritizing care, the nurse must use a framework like the ABCs (Airway, Breathing, Circulation) or Maslow's hierarchy, but in a patient with an active infection and severe immunosuppression, treating the root cause is paramount. The difficulty swallowing is a red flag for esophageal candidiasis, which can lead to dehydration, malnutrition, and further deterioration. The most direct and effective way to prevent these complications is to eradicate the
Candida organism with an antifungal agent. The nurse's priority is to initiate this treatment as ordered and then carefully monitor the child's response, including resolution of oral lesions, improvement in pain, and ability to swallow. This approach aligns with the evidence that managing otorhinolaryngological manifestations in HIV is critical for preventing treatment failure and disease progression
[1].
References (research sources)
- [1]
Oropharyngeal Manifestations in Patients with HIV from Northeastern Romania.Research articleSurdu AE, Loghin II, Dorobăţ VD, Hârtie V, Rusu ȘA, Cecan I, Mihăescu AA, Eva O, Dorobăț CM. (2025) · DOI: 10.3390/medicina61050855
- [2]
Candida parapsilosis Oral Infection in an HIV-Negative Infant With Profound CD4+ Lymphopenia: Unveiling a Rare Immunodeficiency Scenario.Research articleFilippatos F, Karava V, Kakleas K, Santou A, Michos A. (2025) · DOI: 10.7759/cureus.87740